Table 4. Comparison between using single treatment with CDDP or combined treatment of BI7273 with CDDP in MGC-803.
| Anticancer drugs | Cell type | ADR cell viability (%) | ||
|---|---|---|---|---|
| 0.5 µg/mL | 1 µg/mL | 2 µg/mL | ||
| CDDP (µg/mL) | MGC-803 | 94.19 | 84.81 | 23.91 |
| 500 nm BI7273 + CDDP (µg/mL) | MGC-803 | 17.4 | 17.28 | 13.83 |
| 1,000 nm BI7273 + CDDP (µg/mL) | MGC-803 | 13.72 | 12.84 | - |
CDDP, Cisplatin. Concentration gradient of CDDP for MTT is 0, 0.5, 1, 2, 4, and 8 μg/mL.